Endologix, Inc. to Announce First Quarter 2020 Financial Results on May 11, 2020
2020年5月2日 - 5:01AM
ビジネスワイヤ(英語)
Endologix, Inc. (Nasdaq: ELGX), a developer and marketer of
innovative treatments for aortic disorders, today announced that it
will report financial results for the first quarter of fiscal year
2020 after the market close on Monday, May 11, 2020. The Company’s
management will host a conference call at 4:30 p.m. ET that same
day to discuss the results.
To participate in the conference call, dial 800-263-0877
(domestic) or +1 323-794-2094 (international) and refer to the
passcode 4426442.
This conference call will also be webcast and can be accessed
from the “Investors” section of the Company’s website at
www.endologix.com. The webcast replay of the call will be available
at the same site approximately one hour after the end of the
call.
A recording of the call will also be available from 7:30 p.m. ET
on Monday, May 11, 2020, until 11:59 p.m. ET on Monday, May 18,
2020. To hear this recording, dial 844-512-2921 (domestic) or +1
412-317-6671 (international) and enter the passcode 4426442.
About Endologix, Inc.
Endologix, Inc. develops and manufactures minimally invasive
treatments for aortic disorders. The Company's focus is
endovascular stent grafts for the treatment of abdominal aortic
aneurysms (AAA). AAA is a weakening of the wall of the aorta, the
largest artery in the body, resulting in a balloon-like
enlargement. Once an AAA develops, it continues to enlarge and, if
left untreated, becomes increasingly susceptible to rupture. The
overall patient mortality rate for ruptured AAA is approximately
80%, making it a leading cause of death in the United States. For
more information, visit www.endologix.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200501005481/en/
Investors: Endologix, Inc. Vaseem Mahboob, CFO (949)
595-7200
Endologix (NASDAQ:ELGX)
過去 株価チャート
から 12 2024 まで 1 2025
Endologix (NASDAQ:ELGX)
過去 株価チャート
から 1 2024 まで 1 2025
Real-Time news about Endologix Inc (ナスダック市場): 0 recent articles
その他のEndologix, Inc.ニュース記事